CAR-T Clinical Trial

CAR-T Clinical Trial

I am a caregiver for my wife who has follicular lymphoma. In November 2011, at the age of 65, my wife was diagnosed with follicular lymphoma Stage 4, Grade 3A. She had 50% bone marrow involvement. She is one of the 20% of follicular lymphoma patients who progress rapidly after treatments. In 3 years she progressed after R-CHOP (6 cycles), bendamustine/rituximab (6 cycles), and Ibrutinib (12 months). Then she took Idelalisib/rituximab as her fourth treatment. It worked great for 14 months then a PET scan showed she progressed again. She is now in an NIH CAR-T trial NCT02659943 was infused on March 2, 2016. She has been in complete remission for 13 months. Current CAR-T clinical trial data shows that once a follicular lymphoma patient achieves a complete remission they stay in complete remission.

Skip

Featured Content

Free Clinical Research Education Day

Join us for free health screenings, foods, prizes, and educational talks in Houston, May 12th

Register Today

Featured by HealthUnlocked

Clinical Trial Volunteer 5K Run & Walk

Join us for a 5K run in Magnuson Park on April 29th! Our way of celebrating the gift of participation in clinical research.

Learn more

Featured by HealthUnlocked

1 Reply

oldestnewest
  • Hi wmay13241 thank you for sharing your story! So glad to hear the good news regarding your wife's condition.

You may also like...